23, 2002 (Tokyo, Japan) - Aderans Inc., the parent company
of Bosley Medical, announced today that it is setting up a new
company to research both Cell Therapy and Tissue Engineering
as a means to addressing the problem of hair loss.
Dr Ken Washenik - Medical Director of the Aderans Research
new company called Aderans Research Institute, Inc.,
will have its main office in Los Angeles, California, but
the actual research will be conducted at two facilities, one
in Philadelphia, Pennsylvania and one in Atlanta, Georgia.
The facility in Philadelphia will study methods of cell therapy
to induce hair follicle cell growth and will be headed by
Dr. Kurt Stenn, previously of Johnson & Johnson research,
who will also be the Chief Scientific Officer of the new company.
The facility in Atlanta will be run by Thomas Barrows Ph.D.,
a biomaterials polymer chemist previously of Bioamide, Inc.,
and will use tissue engineering to develop methods to package
and implant hair follicle precursors. The entire group will
have a staff of 9 researchers and is being funded by an initial
$400,000 of seed capital provided by Aderans Inc., who is
the sole owner of the company.
has also acquired Bioamide, Inc., and has folded it into their
new facility in Atlanta. The new company will continue working
on Bioamide's technology which has already earned it three
patents with another three patents pending. Bioamide has been
in operation since 1997 and has already made substantial progress
with its tissue engineering approach to creating new follicles.
One issue that slowed down their research was a lack of funding,
so the acquisition of the company by Aderans will alleviate
that problem and allow the research to continue.
technology involves coating fine wires with a special polymer
and then fusing them together. A pore-forming agent in the
polymer is then triggered when researchers submerse the polymer
in hot oil. The high temperature decomposes the pore-forming
agent in something like a foaming process. The result is interconnected
porosity that creates a scaffold with a lot of surface area
where cells can attach and grow. Researchers then remove the
fine stainless steel wire in the scaffold and create even
larger pores that run throughout the scaffold. The intent
is to provide the cells with rapid access to the scaffold
interior so the cells can quickly integrate with vascular
Bioamide has been doing its research in conjunction with the
Center for the Engineering of Living Tissue, a joint venture
between Emory University and Georgia Tech. Thomas Barrows,
who is now heading the new Aderans research institute in Georgia,
co-founded Bioamide Inc. with Katie Mattox in 1997 to develop
tissue-engineered bone for "bone scaffolding," a
biotech process to heal broken bones. Bioamide has already
conducted small scale trials.
Aderans Research Institute will apply the results obtained
from the two facilities to the hair transplantation business
of Bosley Medical Institute, Inc. which Aderans bought last
year. Both facilities will open in July 2002.